Ann: FY21 Q1 Activity Report and Appendix 4C Cashflow Statement, page-72

Bub is not penny stock when it's market cap is $300m.

very overvalued still. nuchev is valued at $70m and also produces goat infant formula under oli6 brand.

Imo Bub is valued at less than 150m. $9m quarterly is really bad sales. don't forget kristy sold a lot of her shares at the top. she's prob looking for an exit. in the end it's the shareholders who lose as management get paid well.

until management can address the quality of the product, I doubt you will see profit for a very long time. more future credit raising to come.

those that blindly believe in bubs, good on you. but you could have sold above $1. so many other growth shares on asx that actually makes money.